Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study of Oral MOA-728 for the Treatment of Opioid- Induced Bowel Dysfunction in Subjects With Chronic Nonmalignant Pain
Conditions
Interventions
N-methylnaltrexone bromide (MOA-728)
placebo
Locations
41
United States
Mobile, Alabama, United States
Litchfield Park, Arizona, United States
Tucson, Arizona, United States
Tucson, Arizona, United States
Hot Springs, Arkansas, United States
Hot Springs, Arkansas, United States
Start Date
October 1, 2007
Primary Completion Date
February 1, 2008
Completion Date
February 1, 2008
Last Updated
August 20, 2020
NCT07462481
NCT07344402
NCT07231796
NCT07091084
NCT07215351
NCT07202481
Lead Sponsor
Bausch Health Americas, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions